Controlled; 100-300 patients with disease for which the drug is being studied; investigates effectiveness and short-term side effects and risks.

• A. Phase 1 Clinical Trial
• B. Viruses
• C. Taq Polymerase
• D. Phase 2 Clinical Trial

Answer: (D)

In clinical trials, the goals and setup change by phase. The description—groups of about a hundred to a few hundred patients who have the disease, a controlled design, and a focus on whether the drug works plus short-term side effects and risks—fits best with a Phase 2 trial. Phase 2 tests the drug’s real-world effectiveness in people who have the condition and keeps monitoring safety, especially short-term adverse effects. It runs after Phase 1, which is mainly about safety and dosage in a smaller group, and before Phase 3, which looks at effectiveness in larger, more diverse populations to confirm results. The other options don’t describe a trial stage: viruses and Taq polymerase are biological agents used in labs, not phases of human drug testing.